Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Irving

Showing results (441-450 of 563) with videos related to

Pageof 57
Sort By:
Journal of Gastroenterology and Hepatology|July 28, 2010
Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndromeDerrick K Ong, Shaylyn B Mitchell, Jacqueline S Barrett, et al.
European Journal of Gastroenterology & Hepatology|March 13, 2008
Platelet-leucocyte aggregates form in the mesenteric vasculature in patients with ulcerative colitisPeter M Irving, Marion G Macey, Roger M Feakins, et al.
Nature|June 22, 1995
Tilting of the light-chain region of myosin during step length changes and active force generation in skeletal muscleM Irving, T St Claire Allen, C Sabido-David, et al.
Journal of Gastroenterology and Hepatology|November 13, 2023
Early recapture of response with tofacitinib 10 mg twice daily in patients with ulcerative colitis in OCTAVE Open following dose reduction or treatment interruption in OCTAVE SustainJessica R Allegretti, Krisztina B Gecse, Michael V Chiorean, et al.
Frontline Gastroenterology|July 6, 2023
How achievable are STRIDE-II treatment targets in real-world practice and do they predict long-term treatment outcomes?Susanna Meade, Emma Routledge, Esha Sharma, et al.
Inflammatory Bowel Diseases|March 15, 2018
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative ColitisPeter M Irving, Tariq Iqbal, Chuka Nwokolo, et al.
Inflammatory Bowel Diseases|September 28, 2019
Infliximab and Adalimumab Concentrations May Vary Between the Enzyme-Linked Immunosorbent Assay and the Homogeneous Mobility Shift Assay in Patients With Inflammatory Bowel Disease: A Prospective Cross-Sectional Observational StudyWilliam T Clarke, Konstantinos Papamichael, Niels Vande Casteele, et al.
The American Journal of Gastroenterology|January 13, 2011
Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trialJessica R Biesiekierski, Evan D Newnham, Peter M Irving, et al.
Frontline Gastroenterology|October 17, 2022
Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort studySailish Honap, Lulia Al-Hillawi, Samantha Baillie, et al.
Aging Cell|October 1, 2021
Ectopic cervical thymi and no thymic involution until midlife in naked mole ratsStephan Emmrich, Frances Tolibzoda Zakusilo, Alexandre Trapp, et al.
Pageof 57

Showing results (441-450 of 563) with videos related to

Sort By:
Pageof 57
Journal of Gastroenterology and Hepatology|July 28, 2010
Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndromeDerrick K Ong, Shaylyn B Mitchell, Jacqueline S Barrett, et al.
European Journal of Gastroenterology & Hepatology|March 13, 2008
Platelet-leucocyte aggregates form in the mesenteric vasculature in patients with ulcerative colitisPeter M Irving, Marion G Macey, Roger M Feakins, et al.
Nature|June 22, 1995
Tilting of the light-chain region of myosin during step length changes and active force generation in skeletal muscleM Irving, T St Claire Allen, C Sabido-David, et al.
Journal of Gastroenterology and Hepatology|November 13, 2023
Early recapture of response with tofacitinib 10 mg twice daily in patients with ulcerative colitis in OCTAVE Open following dose reduction or treatment interruption in OCTAVE SustainJessica R Allegretti, Krisztina B Gecse, Michael V Chiorean, et al.
Frontline Gastroenterology|July 6, 2023
How achievable are STRIDE-II treatment targets in real-world practice and do they predict long-term treatment outcomes?Susanna Meade, Emma Routledge, Esha Sharma, et al.
Inflammatory Bowel Diseases|March 15, 2018
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative ColitisPeter M Irving, Tariq Iqbal, Chuka Nwokolo, et al.
Inflammatory Bowel Diseases|September 28, 2019
Infliximab and Adalimumab Concentrations May Vary Between the Enzyme-Linked Immunosorbent Assay and the Homogeneous Mobility Shift Assay in Patients With Inflammatory Bowel Disease: A Prospective Cross-Sectional Observational StudyWilliam T Clarke, Konstantinos Papamichael, Niels Vande Casteele, et al.
The American Journal of Gastroenterology|January 13, 2011
Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trialJessica R Biesiekierski, Evan D Newnham, Peter M Irving, et al.
Frontline Gastroenterology|October 17, 2022
Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort studySailish Honap, Lulia Al-Hillawi, Samantha Baillie, et al.
Aging Cell|October 1, 2021
Ectopic cervical thymi and no thymic involution until midlife in naked mole ratsStephan Emmrich, Frances Tolibzoda Zakusilo, Alexandre Trapp, et al.
Pageof 57